{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:35:26Z","timestamp":1787236526101,"version":"build-2736575974"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Major depressive disorder (MDD) remains one of the most frequently diagnosed mental health disorders and a leading cause of disability worldwide. The discovery of new treatments for MDD is necessary given up to 30% of individuals with MDD are resistant to current antidepressant treatments. The significant physiological interplay between MDD and metabolic conditions is crucial to consider for future therapeutics given the current obesity epidemic and the increased prevalence of treatment-resistant depression in individuals with metabolic dysfunction. The aim of this review is to discuss the relationship between metabolic dysfunction and MDD, while highlighting the potential antidepressant effects of insulin. There are interconnected perpetuating cycles involving hypothalamic-pituitary-adrenal (HPA) axis dysfunction, inflammation, obesity, insulin resistance, and MDD. Evidence on the efficacy of agents that target insulin resistance for depression is mixed and mechanisms by which these agents may improve depressive symptoms have not been clearly elucidated in studies reporting benefit. While there is a clear need to continue research on treatments that address the burden imposed by treatment-resistant depression, current data on whether insulin-sensitivity-targeting therapies can fill this gap remain limited. Clinically, routine metabolic screening in MDD could guide precision treatments targeting insulin pathways, particularly in those with metabolic dysfunction. Future studies considering the role of insulin, especially in those with insulin resistance, may enable development of novel therapeutics.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1930167","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:43:37Z","timestamp":1787233417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunction and insulin resistance in depression: mechanisms, evidence, and therapeutic implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Katerina","family":"Palacek","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Ottawa","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Corbeil","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Ottawa","place":["Ottawa, ON, Canada"]},{"name":"Ottawa Hospital Research Institute (OHRI), Clinical Epidemiology Program, University of Ottawa","place":["Ottawa, ON, Canada"]},{"name":"Department of Pharmacy, Quebec Mental Health University Institute","place":["Quebec, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saguna","family":"Katyal","sequence":"additional","affiliation":[{"name":"University of Ottawa, School of Epidemiology and Public Health","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Lo Buglio","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Ottawa","place":["Ottawa, ON, Canada"]},{"name":"Ottawa Hospital Research Institute (OHRI), Neuroscience Program, University of Ottawa","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Ottawa","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto","place":["Toronto, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Fabiano","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Ottawa","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11121633","article-title":"Biological, psychological, and social determinants of depression: A review of recent literature","volume":"11","author":"Remes","year":"2021","journal-title":"Brain Sci"},{"key":"B2","unstructured":"Depressive Disorder (Depression)\n          \n          2025"},{"key":"B3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12888-019-2222-4","article-title":"The humanistic and economic burden of treatment-resistant depression in Europe: A cross-sectional study","volume":"19","author":"Jaffe","year":"2019","journal-title":"BMC Psychiatry"},{"key":"B4","unstructured":"One in Eight People are Now Living With Obesity\n          \n          2024"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00527-y","article-title":"Update on the obesity epidemic: After the sudden rise, is the upward trajectory beginning to flatten","volume":"12","author":"Koliaki","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10842","article-title":"Obesity and insulin resistance","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: Connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.20101479","article-title":"Incident major depressive disorder predicted by three measures of insulin resistance: A Dutch cohort study","volume":"178","author":"Watson","year":"2021","journal-title":"Am J Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12052","article-title":"A systematic review of variables associated with the relationship between obesity and depression","volume":"14","author":"Preiss","year":"2013","journal-title":"Obes Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca","year":"2008","journal-title":"FEBS Lett"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101112","article-title":"Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state","volume":"43","author":"Werdermann","year":"2021","journal-title":"Mol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11101298","article-title":"HPA axis in the pathomechanism of depression and schizophrenia: New therapeutic strategies based on its participation","volume":"11","author":"Mikulska","year":"2021","journal-title":"Brain Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3996-2","article-title":"Cerebral cortex: A target and source of insulin","volume":"59","author":"Csajbok","year":"2016","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108819","article-title":"The history of the Nobel prize for the discovery of insulin","volume":"175","author":"Ryden","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126403","article-title":"Role of insulin in health and disease: An update","volume":"22","author":"Rahman","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/1071-5576(95)94135-h","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.rehab.2018.11.001","article-title":"Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"62","author":"Sampath Kumar","year":"2019","journal-title":"Ann Phys Rehabil Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.036467","article-title":"Prevalence of the insulin resistance syndrome in obesity","volume":"90","author":"Viner","year":"2005","journal-title":"Arch Dis Child"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-008-9101-5","article-title":"Beta-cell failure as a complication of diabetes","volume":"9","author":"Chang-Chen","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2013.09.006","article-title":"Skin disorders in overweight and obese patients and their relationship with insulin","volume":"105","author":"Plascencia G\u00f3mez","year":"2014","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cca.2015.01.027","article-title":"Insulin resistance and cognitive dysfunction","volume":"444","author":"Ma","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22153","article-title":"Depression and metabolic syndrome: A narrative review","volume":"14","author":"Al-Khatib","year":"2022","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.10.4.413","article-title":"The inflammatory hypothesis of depression","volume":"10","author":"Soskin","year":"2012","journal-title":"Focus"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.293.3357","article-title":"The fiery landscape of depression: A review of the inflammatory hypothesis","volume":"29","author":"Madeeh Hashmi","year":"2013","journal-title":"Pak J Med Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21110","article-title":"Comorbidity between major depressive disorder and physical diseases: A comprehensive review of epidemiology, mechanisms and management","volume":"22","author":"Berk","year":"2023","journal-title":"World Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0921-0709(05)80006-9","article-title":"Chapter 1.3 - An introduction to the HPA axis","volume":"15","author":"Fulford","year":"2005","journal-title":"Techniques Behav Neural Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158178","article-title":"New insights into the role of insulin and hypothalamic-pituitary-adrenal (HPA) axis in the metabolic syndrome","volume":"23","author":"Janssen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B30","article-title":"Physiology, cortisol","volume-title":"Treasure Island (FL): Statpearls Publishing","author":"Thau","year":"2023"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e31820ad12b","article-title":"Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research","volume":"73","author":"Stetler","year":"2011","journal-title":"Psychosom Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X21666230811141557","article-title":"The HPA axis as target for depression","volume":"22","author":"Menke","year":"2024","journal-title":"Curr Neuropharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113146","article-title":"The etiology of poststroke-depression: A hypothesis involving HPA axis","volume":"151","author":"Zhou","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26072940","article-title":"Chronic stress-associated depressive disorders: The impact of HPA axis dysregulation and neuroinflammation on the hippocampus-a mini review","volume":"26","author":"Lei","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c150015","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr Physiol"},{"key":"B36","unstructured":"Spotlight on Diabetes Data: United States Diabetes Surveillance System"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","article-title":"Why does obesity cause diabetes","volume":"34","author":"Klein","year":"2022","journal-title":"Cell Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e3283514e13","article-title":"What causes the insulin resistance underlying obesity","volume":"19","author":"Hardy","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.11.001","article-title":"Obesity and insulin resistance: Pathophysiology and treatment","volume":"27","author":"Tong","year":"2022","journal-title":"Drug Discov Today"},{"key":"B40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","article-title":"Mechanisms of inflammatory responses and development of insulin resistance: How are they interlinked","volume":"23","author":"Rehman","year":"2016","journal-title":"J BioMed Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186969","article-title":"Clinical evidence of antidepressant effects of insulin and anti-hyperglycemic agents and implications for the pathophysiology of depression-a literature review","volume":"21","author":"Woo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109720","article-title":"Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants","volume":"95","author":"Grigolon","year":"2019","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0347-4","article-title":"Depression in type 2 diabetes mellitus: Prevalence, impact, and treatment","volume":"75","author":"Semenkovich","year":"2015","journal-title":"Drugs"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1442","article-title":"A systematic review and meta-analysis of the association between depression and insulin resistance","volume":"36","author":"Kan","year":"2013","journal-title":"Diabetes Care"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00057","article-title":"Insulin resistance as a shared pathogenic mechanism between depression and type 2 diabetes","volume":"10","author":"Lyra","year":"2019","journal-title":"Front Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2014.02.036","article-title":"Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system","volume":"129","author":"Gupta","year":"2014","journal-title":"Physiol Behav"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105179","article-title":"Impact of insulin and insulin resistance on brain dopamine signalling and reward processing - An underexplored mechanism in the pathophysiology of depression","volume":"149","author":"Gruber","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12806","article-title":"Potential role of insulin on the pathogenesis of depression","volume":"53","author":"Zou","year":"2020","journal-title":"Cell Proliferation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainresbull.2018.09.017","article-title":"Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain","volume":"143","author":"Mueller","year":"2018","journal-title":"Brain Res Bull"},{"key":"B50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41398-022-01943-9","article-title":"IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine","volume":"12","author":"Deyama","year":"2022","journal-title":"Transl Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-015-9575-3","article-title":"The beneficial impact of antidepressant drugs on prenatal stress-evoked malfunction of the insulin-like growth factor-1 (IGF-1) protein family in the olfactory bulbs of adult rats","volume":"29","author":"Trojan","year":"2016","journal-title":"Neurotox Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12888-020-02636-7","article-title":"Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study","volume":"20","author":"Levada","year":"2020","journal-title":"BMC Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00621-5","article-title":"Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder","volume":"76","author":"Krupa","year":"2024","journal-title":"Pharmacol Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000905","article-title":"Consolidating evidence on the role of insulin resistance in major depressive disorder","volume":"37","author":"Krupa","year":"2024","journal-title":"Curr Opin Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.5.1.157","article-title":"The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms","volume":"5","author":"McIntyre","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.02.013","article-title":"Body weight as a predictor of antidepressant efficacy in the GENDEP project","volume":"118","author":"Uher","year":"2009","journal-title":"J Affect Disord"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291722003233","article-title":"Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment refractory depression and suicidal behavior","volume":"53","author":"Pan","year":"2023","journal-title":"Psychol Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1192\/bjp.2025.82","article-title":"Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care data","volume":"229","author":"Fanelli","year":"2026","journal-title":"Br J Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104758","article-title":"Insulin resistance in depression: a large meta-analysis of metabolic parameters and variation","volume":"139","author":"Fernandes","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-03083-0","article-title":"Evidence of bidirectional relationship between type 2 diabetes and depression; a Mendelian randomization study","volume":"30","author":"Bala","year":"2025","journal-title":"Mol Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12265","article-title":"Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus","volume":"41","author":"Guo","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/NDT.S121149","article-title":"Pioglitazone could induce remission in major depression: a meta-analysis","volume":"13","author":"Colle","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41398-022-02234-z","article-title":"Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers","volume":"12","author":"Toba-Oluboka","year":"2022","journal-title":"Transl Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120783","article-title":"The association between depressive symptom severity and metabolic disturbances in major depressive and bipolar disorders: a systematic review and meta-analysis","volume":"395","author":"Wong","year":"2025","journal-title":"J Affect Disord"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8227(01)00327-8","article-title":"Insulin improves well-being for selected elderly type 2 diabetic subjects","volume":"55","author":"Reza","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2003.11.001","article-title":"A randomised trial of insulin on well-being and carer strain in elderly type 2 diabetic subjects","volume":"18","author":"Hendra","year":"2004","journal-title":"J Diabetes Complications"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958001-00009","article-title":"The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms","volume":"58","author":"Wiernsperger","year":"1999","journal-title":"Drugs"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.09.015","article-title":"Association of metformin and depression in patients with type 2 diabetes","volume":"318","author":"Yu","year":"2022","journal-title":"J Affect Disord"},{"key":"B71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.psyneuen.2018.05.010","article-title":"Repositioning of diabetes treatments for depressive symptoms: a systematic review and meta-analysis of clinical trials","volume":"94","author":"Moulton","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10843","article-title":"Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists","volume":"106","author":"Olefsky","year":"2000","journal-title":"J Clin Invest"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084334","article-title":"The role of GLP-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome","volume":"23","author":"Bednarz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2023.05.041","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review","volume":"164","author":"Cooper","year":"2023","journal-title":"J Psychiatr Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s40001-025-02871-2","article-title":"Association of antidiabetic medications with psychiatric disorders in patients with type 2 diabetes: a cross-sectional study","volume":"30","author":"Mansour","year":"2025","journal-title":"Eur J Med Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2009.175489","article-title":"Improved insulin sensitivity after weight loss and exercise training is mediated by a reduction in plasma fatty acid mobilization, not enhanced oxidative capacity","volume":"587","author":"Schenk","year":"2009","journal-title":"J Physiol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2022-106282","article-title":"Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression","volume":"57","author":"Heissel","year":"2023","journal-title":"Br J Sports Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030176","article-title":"Diet, obesity, and depression: a systematic review","volume":"11","author":"Patsalos","year":"2021","journal-title":"J Pers Med"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1930167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:43:47Z","timestamp":1787233427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1930167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":78,"alternative-id":["10.3389\/fpsyt.2026.1930167"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1930167","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1930167"}}